Cardiac Syndrome X Treatment
Treatment options for controlling the symptoms of cardiac syndrome x include:
- Lower blood pressure and reduce the work of the heart
- Metoprolol (Lopressor, Toprol XL)
- Propranolol (Inderal)
- Atenolol (Tenormin)
- Calcium-channel blockers:
- Reduce the work of the heart and reduce abnormal heartbeats
- Amlodipine (Norvasc)
- Diltiazem (Cardizem CD, Dilacor)
- Verapamil (Calan)
- May help reduce chest pain in patients with normal or near-normal coronary arteries.
Cardiac Syndrome X Questions For Doctor
The following are some important questions to ask before and after the treatment of cardiac syndrome X.
Questions to ask before treatment:
- What are my treatment options?
- Is surgery an option for me?
- What are the risks associated with treatment?
- Do I need to stay in the hospital?
- How long will I be in the hospital?
- What are the complications I should watch for?
- How long will I be on medication?
- What are the potential side effects of my medication?
- Does my medication interact with nonprescription medicines or supplements?
- Should I take my medication with food?
Questions to ask after treatment:
- Do I need to change my diet?
- Are there any medications or supplements I should avoid?
- Do I need to lose weight?
- When can I resume my normal activities?
- When can I return to work?
- Do I need a special exercise program?
- Will I need physical therapy?
- Will I need occupational therapy?
- What else can I do to reduce my risk for having this problem again?
- How often will I need to see my doctor for checkups?
- What local support and other resources are available?
Cardiac Syndrome X Specialist
Continue to Cardiac Syndrome X Home Care
- Asbury EA, Collins P. Cardiac syndrome X. Int J Clin Pract. 2005 Sep;59(9):1063-9. 
- Kaski JC, Aldama G, Cosin-Sales J. Cardiac syndrome X. Diagnosis, pathogenesis and management. Am J Cardiovasc Drugs. 2004;4(3):179-94. 
- Mirza MA. Anginalike pain and normal coronary arteries. Uncovering cardiac syndromes that mimic CAD. Postgrad Med. 2005 May;117(5):41-6, 54.